Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Drug-Coated Balloons Market Valuation Change Between Now And 2029?

In the past few years, the market size for drug-coated balloons has seen a fast-paced expansion. The market is projected to swell from $1.08 billion in 2024 to $1.24 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.6%. Factors contributing to the growth during the historic period include an uptick in cardiovascular illnesses, rising demand for less invasive surgical procedures, the widespread occurrence of peripheral artery malady (PAD), decreased restenosis rates, and advancements in the field of interventional cardiology.

In the years to come, the drug-coated balloons market size is projected to experience swift growth, reaching a value of $2.2 billion in 2029 with a compound annual growth rate (CAGR) of 15.5%. The expansion during the forecasted period can be associated with factors such as the growing aging population, broader indications and applications, emphasis on outpatient and ambulatory care, integration with drug delivery innovations, and global health initiatives. The forecast period will also see significant trends like regulatory approvals for novel formulations, efforts to reduce side effects, the rise of bioresorbable coatings, expansion of the market in emerging economies, and patient-oriented approaches.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What Growth-Enabling Forces Are Impacting The Drug-Coated Balloons Market?

The increase in coronary artery disease cases is predicted to fuel the expansion of the market for drug-coated balloons. Coronary artery disease (CAD) is a health issue characterized by the constriction or blockage of the coronary arteries, which supply blood to the heart muscle, resulting in heart attacks. A drug-coated balloon is a medical tool utilized in the treatment of coronary artery disease, with the drug being released into the artery during the procedure to avoid restenosis, the subsequent contraction of the artery post-angioplasty. For example, a study published in the Journal of the American College of Cardiology in August 2022 revealed that all four cardiovascular risk factors are projected to increase in the general U.S. population between 2025 and 2060. Diabetes is predicted to spike the most, by 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. The study also found that heart failure (33.4%) and ischemic heart disease (30.7%) are forecasted to witness the most significant escalation in rates, subsequently followed by heart attacks (16.9%) and strokes (33.8%). Consequently, the surge in coronary artery disease cases is anticipated to propel the drug-coated balloon market.

What Are The Main Segment Classifications In The Drug-Coated Balloons Market?

The drug-coated balloonsmarket covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

How Are Industry Trends Steering The Expansion Of The Drug-Coated Balloons Market?

One of the prominent trends in the drug-coated balloon market is product innovation. Many of the primary market players are investing in the development of technologically advanced and innovative solutions to secure their market standing. For example, Becton, Dickinson, and Company (BD), a medical technology company based in the US, in August 2022, launched the PREVISION trial, a pioneering venture involving a peripheral sirolimus drug-coated balloon (DCB). The objective of this trial is to evaluate the safety and potential benefits of the sirolimus DCB in the treatment of patients suffering from peripheral artery disease, a disorder that greatly affects patients’ mobility and life quality.

Which Firms Are Driving Innovation Within The Drug-Coated Balloons Market?

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

What Are The Emerging Regional Trends Driving The Drug-Coated Balloons Market?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Browse Through More Reports Similar to the Global Drug-Coated Balloons Market 2025, By The Business Research Company

Pta Balloon Catheter Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

Antispasmodics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model